All Online

1 - 12 of 61 results

Refine

Active filters

Infectious Diseases
0.5 CME CREDIT

In the eleventh episode of Pri-Med’s weekly web series on COVID-19, faculty will discuss recent publications and issues related to COVID-19 including the retraction of two major trials on hydroxychloroquine from Lancet and NEJM, the results of a trial investigating hydroxychloroquine as post-exposure prophylaxis for COVID-19, and the results of a study investigating transmission and viral shedding of COVID-19. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 6/10/2020 and they are subject to change as new information is published.


0.5 CME CREDIT

In the twelfth episode of Pri-Med’s weekly web series on COVID-19, faculty will discuss the most recent information on COVID-19 vaccines and testing. This episode will review the mechanisms and clinical trial status of each vaccine currently in development and discuss recent literature comparing different sampling techniques in COVID-19 testing. Lastly, faculty will explore how pre-test probability is important to understanding test accuracy. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 6/16/2020 and they are subject to change as new information is published.


0.5 CME CREDIT

Get your questions answered by an expert faculty in Infectious Disease. You ask: we listen. You will learn practical solutions to common clinical challenges and tips to apply the latest knowledge in practice. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on February 7, 2020, and they are subject to change as new information is published.


0.25 CME CREDIT

This episode will review clinical decision-making tools for diagnosing and treating Streptococcal pharyngitis and will discuss a recent randomized controlled trial utilizing a 5-day course of Penicillin for treatment.


0.25 CME CREDIT

This episode will review the latest data on the pandemic in a patient-centered manner.


0.25 CME CREDIT

Review the latest recommendations from the CDC to assist in responding to patient questions and concerns.


0.25 CME CREDIT

Antibiotics are frequently prescribed for upper respiratory infections, even when they are likely due to viral etiologies, or will resolve just as quickly without antibiotics. Many clinicians believe convincing patients they do not need to take an antibiotic is time consuming and frustrating for both parties. In fact, patients are often receptive to information on appropriate use, and the conversation can be done efficiently with practice.


0.5 CME CREDIT

Unlike HIV with rates of mortality that decline yearly, TB remains the leading infectious cause of death worldwide, accounting for 1.3 million deaths in 2016. Approximately 2 billion people in the world and 10 to 15 million Americans have latent TB infection (LTBI). Although they are not infectious, up to 10% each year are at risk of progression to active disease, depending on their risk factors and co-morbidities. This presentation will compare modalities to diagnose LTBI: the tuberculin skin test (or PPD) and the interferon gamma release assay (e.g., the quantiferon gold blood test). The faculty will discuss which patients are at high risk for progression to TB disease and the role of preventive chemotherapy. Finally, you will learn more about the emerging global storm that awaits us as diabetes becomes epidemic and merges with TB, as there is a 2-4-fold increased risk for TB in patients with diabetes.


1 CME CREDIT

This lecture will focus on known and established pathogenesis of HIV, emphasizing the damage to the immune system as well as illnesses that primary care clinicians may encounter. With expanded knowledge of therapeutic strategies to regain and maintain health, you can address complications that arise with your patients and recognize when to refer. The faculty will also discuss issues that an aging HIV population may face and how to treat them. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on 2/8/2020, and they are subject to change as new information is published.


1 CME CREDIT

This session will review the indications, risks, and benefits of commonly recommended vaccines. Most of the session will focus on communication strategies to enhance trust in the context of working with vaccine-resistant or vaccine-hesitant patients and parents. You will have the opportunity to engage with motivational interviewing strategies that you can use in your practice. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on February 7, 2020, and they are subject to change as new information is published.


1 CME CREDIT

Chronic Kidney Disease: A Primer for Pri-Med

1.00 CME
1.00 AANP | 0.21 Pharmacology

Chronic kidney disease is common, yet many clinicians find it intimidating to manage. This session will give you the tools that you need to identify renal disease, recognize which patients are at risk for a decline in renal function, and practice the components of care. This activity will also discuss the potential interaction between renal physiology and COVID-19 Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 05/08/2020 and they are subject to change as new information is published.


1 CME CREDIT

In this session, the speaker will discuss some challenging diagnostic cases that primary care practitioners may face in their practice. These cases will feature interpretation of laboratory and imaging studies as well as encounters with rare diseases and conditions. You will learn which aspects of the history and physical exam are most useful to establish certain diagnoses, increase your awareness of certain uncommon but “can’t miss” diagnoses, and become familiar with clinical decision aids that improve diagnostic accuracy for certain common diagnoses. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on February 8th, 2020, and they are subject to change as new information is published.